![](/img/cover-not-exists.png)
559 ERBB4 is a Therapeutic Target in Melanoma Resistant to Braf Inhibitors
Amato, C.M., Su, L.J., Robinson, S.E., Gonzalez, R.T., Robinson, W.A.Volume:
48
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/S0959-8049(12)72356-0
Date:
November, 2012
File:
PDF, 75 KB
english, 2012